EXPERTISE
Life Sciences & Healthcare

Guidance on FDI screening obligations in Austria

December 2025 – The Austrian ministry responsible for Foreign Direct Investment (FDI) matters, the Federal Ministry for Economy, Energy, and Tourism (“the Ministry”), recently released guidance on the assessment of the filing obligation for foreign...

NIS2 and the New Serbian Law on Information Security

December 2025 – The Republic of Serbia has adopted a new Law on Information Security (Zakon o informacionoj bezbednosti) (“Serbian NIS2”), marking a significant reform of the national cybersecurity framework and alignment with the EU NIS2 Directive....

A sector under the spotlight: what recent cases in Romania and at the EU level signal for pharma compliance

November 2025 – Competition and regulatory authorities across Europe are showing renewed vigilance toward the pharmaceutical sector—a field shaped by the intersection of competition law, regulatory frameworks, consumer protection, and IP. Recent cases...

Kinstellar advises Integral Capital Group on the acquisition of a majority stake in IVF clinic Calla, via its subsidiary Embryos

November 2025 – Kinstellar has advised Integral Capital Group, a leading private equity firm in Central and Eastern Europe, on the acquisition of a majority stake in Calla Clinic, an in vitro fertilization (IVF) clinic in Oradea, Romania, through its...

Croatia introduces Draft Foreign Direct Investment Screening Act

September 2025 – The Croatian Government has introduced the Draft Act on the Screening of Foreign Investments, which is currently undergoing public consultations. The Draft Act seeks to establish a foreign direct investment (FDI) screening mechanism...

Kinstellar advises GTCR on its acquisition of Zentiva

September 2025 – Kinstellar has successfully advised GTCR, a leading US-based private equity firm, on its agreement to acquire Zentiva, a prominent European generics pharmaceutical company, from global private equity investor Advent International. The...

Updates on NIS2 in Romania

August 2025 – Following up on our initial article regarding the transposition of the NIS2 Directive (EU) 2022/2555 (“NIS2”) in Romania via Government Emergency Ordinance no. 155/30.12.2024 (“GEO 155”), we would like to inform you of the following...

Navigating NIS 2: How businesses can achieve cybersecurity compliance across the EU

August 2025 - The NIS 2 Directive is the European Union’s cybersecurity framework that requires considerable efforts by companies in sectors like energy, transportation, life sciences and digital infrastructure to establish the required compliance....

Kinstellar, together with Addleshaw Goddard as lead counsel, advises Phoenix Equity Partners Limited on the acquisition of FutureMeds in Bulgaria and Ukraine

August 2025 – Kinstellar, together with Addleshaw Goddard as lead counsel, has advised Phoenix Equity Partners Limited, a leading UK-based private equity investor, in connection with the acquisition by Phoenix of FutureMeds, a fast-growing clinical...

Kinstellar advises on the financial close of Central Asia’s largest healthcare PPP project in Kazakhstan

May 2025 – Kinstellar is delighted to announce the successful financial close of a landmark public-private partnership (PPP) healthcare initiative in Kokshetau, Kazakhstan. This transformative project, which marks a first for the region in healthcare...